Kures, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.kuresinc.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults
- First Posted Date
- 2021-11-09
- Last Posted Date
- 2022-12-14
- Lead Sponsor
- Kures, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05114265
- Locations
- 🇳🇿
KUR-101-101 Clinical Research Site, Christchurch, New Zealand
News
No news found